Download the Use Case Spotlight:
How a Leading Biopharma Organization Scaled Precision Oncology
Accelerating Biomarker-Driven Oncology Evidence With Multi-Modal Real-World Data
Download the Use Case Spotlight to see how leading biopharma organizations are using Translational360™ to connect multi-modal molecular data with longitudinal clinical outcomes to accelerate precision oncology research, biomarker validation, and treatment sequencing decisions.
Inside this spotlight, you’ll learn how integrated real-world evidence supported deeper understanding of MET biology in gastric and GEJ cancer, enabled more precise patient stratification, and informed translational development strategies at scale.
ConcertAI's Precision Trials™
Power clinical trial success with AI-driven design, predictive site selection, and real-world patient insights.
What is PrecisionTrials™?
+
PrecisionTrials™ is ConcertAI’s SaaS solution that combines real-world data with agentic and generative AI to optimize clinical trial design, site strategy, and patient recruitment forecasting.
How does PrecisionTrials™ improve trial design?
+
It enables AI-driven cohort definition and simulation of study outcomes, helping teams refine inclusion/exclusion criteria and forecast enrollment before launch.
Can PrecisionTrials™ enhance patient recruitment?
+
Yes — it uses near real-time oncology real-world data and predictive models to identify eligible patients and reduce screen failure rates, accelerating enrollment.
How does PrecisionTrials™ support site selection?
+
The platform recommends optimal trial sites based on historical performance, patient volume, and diversity goals, reducing non-productive sites and improving per-patient operational efficiency.
What value does PrecisionTrials™ deliver to timelines and costs?
+
PrecisionTrials™ helps cut unplanned study amendments by up to 50%, eliminate months of amendment-related delays, and shorten overall trial timelines — accelerating time to commercial launch.
Who benefits most from PrecisionTrials™?
+
Clinical Development and Clinical Operations teams benefit significantly — from eligibility criteria planning and feasibility validation to efficient execution and site strategy optimization.